BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 25293799)

  • 1. [A case of percutaneous BCG perfusion therapy for CIS of upper urinary tract CIS after radical cystectomy with ileal neobladder].
    Obayashi K; Miki J; Kasai K; Tashiro K; Tsuduki S; Bando S; Ishii G; Suzuki K; Kimura T; Kishimoto K; Egawa S
    Hinyokika Kiyo; 2014 Sep; 60(9):443-6. PubMed ID: 25293799
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bacillus Calmette-Guérin treatment of urothelial carcinoma arising in the ileal neobladder after radical cystectomy.
    Yamashita R; Matsuzaki M; Niwakawa M; Ito I
    Int J Urol; 2014 Mar; 21(3):333-4. PubMed ID: 23991753
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravesical instillations with bacillus calmette-guérin for the treatment of carcinoma in situ involving prostatic ducts.
    Palou Redorta J; Schatteman P; Huguet Pérez J; Segarra Tomás J; Rosales Bordes A; Algaba F; Villavicencio Mavrich H
    Eur Urol; 2006 May; 49(5):834-8; discussion 838. PubMed ID: 16426729
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical outcome of bacillus Calmette-Guérin perfusion therapy for carcinoma in situ of the upper urinary tract.
    Miyake H; Eto H; Hara S; Okada H; Kamidono S; Hara I
    Int J Urol; 2002 Dec; 9(12):677-80. PubMed ID: 12492951
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bacillus Calmette-Guérin failure in patients with non-muscle-invasive urothelial carcinoma of the bladder may be due to the urologist's failure to detect urothelial carcinoma of the upper urinary tract and urethra.
    Giannarini G; Birkhäuser FD; Recker F; Thalmann GN; Studer UE
    Eur Urol; 2014 Apr; 65(4):825-31. PubMed ID: 24144432
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The diagnosis and treatment for carcinoma in situ of the bilateral upper urinary tracts after total cystectomy and ileal conduit by intentionally inducing hydronephrosis].
    Saito J; Kato T; Kakuta Y; Tanaka M; Yazawa K; Hosomi M; Ito K
    Hinyokika Kiyo; 2006 Jul; 52(7):573-5. PubMed ID: 16910594
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cystectomy in patients with high risk superficial bladder tumors who fail intravesical BCG therapy: pre-cystectomy prostate involvement as a prognostic factor.
    Huguet J; Crego M; Sabaté S; Salvador J; Palou J; Villavicencio H
    Eur Urol; 2005 Jul; 48(1):53-9; discussion 59. PubMed ID: 15967252
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Intrarenal Bacillus Calmette-Guerin perfusion therapy was effective for carcinoma in situ of the upper urinary tract after ileal conduit replacement : a case report].
    Hayashi T; Yamanaka Y; Kinjo T; Katayama K; Kamoto A; Mori N; Yoshioka T
    Hinyokika Kiyo; 2014 Apr; 60(4):175-8. PubMed ID: 24882229
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term follow-up of intravesical bacillus Calmette-Guérin treatment for superficial transitional-cell carcinoma of the bladder involving the prostatic urethra.
    Taylor JH; Davis J; Schellhammer P
    Clin Genitourin Cancer; 2007 Sep; 5(6):386-9. PubMed ID: 17956711
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Percutaneous Bacillus Calmette-Guerin perfusion of the upper urinary tract for carcinoma in situ].
    Yamashita S; Yogi Y; Taniguchi K; Morimitsu H; Suzu H; Kanetake H; Saito Y; Kubota S
    Hinyokika Kiyo; 1992 Oct; 38(10):1095-9. PubMed ID: 1481770
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The influence over the long-term prognosis of BCG therapy and the surgical treatment in superficial bladder cancer treatment].
    Higashi S; Matsui Y; Takahashi T; Nishiyama H; Ito N; Yamamoto S; Kamoto T; Ogawa O
    Hinyokika Kiyo; 2005 Aug; 51(8):529-31. PubMed ID: 16164268
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Efficacy of intravesical bacillus Calmette-Guerin for carcinoma in situ of bladder].
    Uekado Y; Kohjimoto Y; Iba A; Kikkawa K; Shintani Y; Shinka T
    Hinyokika Kiyo; 2006 Jun; 52(6):439-44. PubMed ID: 16848357
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Urethral recurrence of invasive carcinoma following BCG treatment for bladder Ca in situ].
    Ruoppolo M; Gozo M; Milesi R; Spina R; Fragapane G
    Urologia; 2010; 77 Suppl 17():72-7. PubMed ID: 21308679
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcomes of intrarenal Bacillus Calmette-Guérin/interferon-α2B for biopsy-proven upper-tract carcinoma in situ.
    Shapiro EY; Lipsky MJ; Cha DY; McKiernan JM; Benson MC; Gupta M
    J Endourol; 2012 Dec; 26(12):1645-50. PubMed ID: 22834939
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bacillus Calmette-Guérin perfusion therapy for the treatment of transitional cell carcinoma in situ of the upper urinary tract.
    Nonomura N; Ono Y; Nozawa M; Fukui T; Harada Y; Nishimura K; Takaha N; Takahara S; Okuyama A
    Eur Urol; 2000 Dec; 38(6):701-4;discussion 705. PubMed ID: 11111187
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term effects of bacille Calmette-Guérin perfusion therapy for treatment of transitional cell carcinoma in situ of upper urinary tract.
    Hayashida Y; Nomata K; Noguchi M; Eguchi J; Koga S; Yamashita S; Hayashi M; Kanatake H
    Urology; 2004 Jun; 63(6):1084-8. PubMed ID: 15183955
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Transitional cell carcinoma in prostate after intravesical instillation of Bacillus Calmette-Guerin].
    Ito Y; Nishiyama H; Higashi S; Kinoshita H; Ito N; Yamamoto S; Kamoto T; Ogawa O
    Hinyokika Kiyo; 2004 May; 50(5):335-8. PubMed ID: 15237488
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Carcinoma in situ of the bladder involving the prostate with an unusual invasive pattern following BCG therapy: a case report].
    Iba A; Kohjimoto Y; Inagaki T; Suzuki A; Fujii R; Senzaki H; Uekado Y; Shinka T
    Hinyokika Kiyo; 2005 Oct; 51(10):681-4. PubMed ID: 16285623
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In situ transitional cell carcinoma involvement of prostatic urethra: bacillus Calmette-Guérin therapy without previous transurethral resection of the prostate.
    Palou J; Xavier B; Laguna P; Montlleó M; Vicente J
    Urology; 1996 Apr; 47(4):482-4. PubMed ID: 8638354
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical outcomes of bacillus Calmette-Guérin instillation therapy for carcinoma in situ of urinary bladder.
    Takenaka A; Yamada Y; Miyake H; Hara I; Fujisawa M
    Int J Urol; 2008 Apr; 15(4):309-13. PubMed ID: 18380817
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.